药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Insulin detemir
Ocinaplon
The risk or severity of adverse effects can be increased when Ocinaplon is combined with Levomilnacipran.
Insulin detemir
Tramiprosate
The risk or severity of adverse effects can be increased when Tramiprosate is combined with Levomilnacipran.
Insulin detemir
Clomethiazole
The risk or severity of adverse effects can be increased when Clomethiazole is combined with Levomilnacipran.
Insulin detemir
Remacemide
The risk or severity of adverse effects can be increased when Remacemide is combined with Levomilnacipran.
Insulin detemir
Dotarizine
The risk or severity of adverse effects can be increased when Dotarizine is combined with Levomilnacipran.
Insulin detemir
Ziconotide
The risk or severity of adverse effects can be increased when Ziconotide is combined with Levomilnacipran.
Insulin detemir
Tolperisone
The risk or severity of adverse effects can be increased when Tolperisone is combined with Levomilnacipran.
Insulin detemir
Lacosamide
The risk or severity of adverse effects can be increased when Lacosamide is combined with Levomilnacipran.
Insulin detemir
YKP-1358
The risk or severity of adverse effects can be increased when YKP-1358 is combined with Levomilnacipran.
Insulin detemir
Lumateperone
The risk or severity of adverse effects can be increased when Lumateperone is combined with Levomilnacipran.
Insulin detemir
Gantacurium
The risk or severity of adverse effects can be increased when Gantacurium is combined with Levomilnacipran.
Insulin detemir
BL-1020
The risk or severity of adverse effects can be increased when BL-1020 is combined with Levomilnacipran.
Insulin detemir
PRX-08066
The risk or severity of adverse effects can be increased when PRX-08066 is combined with Levomilnacipran.
Insulin detemir
Naluzotan
The risk or severity of adverse effects can be increased when Naluzotan is combined with Levomilnacipran.
Insulin detemir
Naronapride
The risk or severity of adverse effects can be increased when Naronapride is combined with Levomilnacipran.
Insulin detemir
Brivaracetam
The risk or severity of adverse effects can be increased when Brivaracetam is combined with Levomilnacipran.
Insulin detemir
Methsuximide
The risk or severity of adverse effects can be increased when Methsuximide is combined with Levomilnacipran.
Insulin detemir
Tetrodotoxin
The risk or severity of adverse effects can be increased when Tetrodotoxin is combined with Levomilnacipran.
Insulin detemir
APD791
The risk or severity of adverse effects can be increased when APD791 is combined with Levomilnacipran.
Insulin detemir
Ezogabine
The risk or severity of adverse effects can be increased when Ezogabine is combined with Levomilnacipran.